HMGB1 and Cognitive impairment: An experimental model of CCH in a previous study demonstrated that the administration of anti-HMGB1 neutralizing antibody (Ab) at the acute stage of ischemia could reserve hippocampal neuronal death and improve cognitive impairment [22].